English - Fraunhofer IME

Teasers Set

Aachen | Münster

Moleculare Biotechnology

Functional and Applied Genomics

Industrial Biotechnology

Integrated Production Plattforms

Plant Biotechnology

Fraunhofer IME

Research from molecule to ecosystem

Welcome to the Fraunhofer IME. We conduct research in the field of applied life sciences from a molecular level to entire ecosystems and are your partner for contract research in the areas of pharmacy, medicine, chemistry, agriculture, as well as environmental and consumer protection. Our research and development portfolio is focused on industry, small and medium enterprises and on the public sector.

The overarching goal of our research activities at Fraunhofer IME is the development and use of novel technologies for diagnosis and therapy of human and animal diseases as well as the protection of crop plants and food sources.

Schmallenberg | Gießen

Applied Ecology and Bioresources

Applied Ecology

Bioresources

Frankfurt am Main | Hamburg

Translational Medicine

Translational Medicine and Pharmacology

ScreeningPort

Teasers Set

29.10.2018

Fraunhofer IME at MEDICA and COMPAMED

»Save the date« From the 12th to the 15th of November 2018, in cooperation with the Fraunhofer Institutes for Manufacturing Technology and Applied Materials Research IFAM, for Cell Therapy and Immunology IZI and for Toxicology and Experimental Medicine ITEM, the Fraunhofer IME exhibitis its novel implant surfaces at the MEDICA and COMPAMED trade fairs in Düsseldorf (Hall 8a, Stand P13). These surfaces protect patients against inflammation at newly inserted implants.

Press Release

24.10.2018

Plant scientists support precision breeding

European scientists unite to safeguard precision breeding for sustainable agriculture - Leading scientists representing more than 85 European plant and life sciences research centers and institutes have endorsed a position paper that urgently calls upon European policy makers to safeguard innovation in plant science and agriculture. Prof. Dr. Stefan Schillberg signed the paper for the Fraunhofer IME.

More Information

15.10.2018

Fraunhofer magazine 1.2018

In the latest issue of the Fraunhofer magazine you get insights into the research at the Fraunhofer IME: In the lead article “Health Research in 4D“ you can read more about clinical trials at the Frankfurt site (page 8). Prof. Dr. Dr. Gerd Geißlinger, the managing director of the Fraunhofer IME and the Medical Research Officer of the Fraunhofer-Gesellschaft, explains in an interview why the Fraunhofer-Gesellschaft is in a unique position to tackle the challenges of medical researchand to pull together the four key areas of biomedicine – drugs, diagnostics, data and devices. (page 17).

More Information

6.8.2018

Chilean-German project meeting

On August 1st and 2nd, scientists of the Chilean- German project "MoMaPo" met at the Fraunhofer IME in Aachen.

The aim of the binational cooperation project "MoMaPo" is the identification of molecular markers for an increased anthocyanin content in potato tubers. Molecular markers are a tool of modern breeding. With their help, the breeders can succeed in developing new varieties in a shorter time compared to classical breeding.

Press Release

1.8.2018

License Agreement with LenioBio

Life sciences startup LenioBio GmbH and the Fraunhofer IME announced today the signing of an exclusive license agreement that allows LenioBio to utilize Fraunhofer’s proprietary vector solution and technology for the cryopreservation of cell-free lysates. The optimized vector solution and cryopreservation technology from Fraunhofer IME has been specifically developed to meet the wide application areas LenioBio is targeting.
With the addition of the Fraunhofer IME license, LenioBio is extending the patent family covering this innovative cell-free system.

Press release

30.7.2018

Fraunhofer ATTRACT Eco'n'OMICs started

On July 1st, the Fraunhofer ATTRACT Eco'n'OMICs started at the location Schmallenberg (Applied Ecology). The group works on OMICs based detection of ecotoxicological effects in the scope of screening series for active ingredient precursors of e.g. plant protection products. Head of the ATTRACT group is Dr. Sebastian Eilebrecht.

More Information

1.7.2018

Prof. Gerd Geißlinger appointed

On July 1st, the Executive Board of the Fraunhofer-Gesellschaft appointed Prof. Dr. Dr. Gerd Geißlinger as executive director of the Fraunhofer IME. Since January 2017, he has held this position as acting executive director. He is also Professor of Clinical Pharmacology and Director of the Institute of Clinical Pharmacology at the Johann Wolfgang Goethe University Frankfurt am Main.

Prof. Dr. Stefan Schillberg and Prof. Dr. Christoph Schäfers will continue to be acting members of the institute's management.